Bruker Corporation (NASDAQ: BRKR) announces the acquisition of biocrates life sciences ag, located in Innsbruck, Austria. biocrates is a global leader in mass spectrometry (MS)-based quantitative metabolite and lipid analysis kits, assays, software and services that make standardized metabolomics accessible to laboratories worldwide. The biocrates kits cover over 1,000+ metabolites from more than 40 metabolite classes, and the biocrates metabolomics technology platform combines innovative sample preparation, metabolite identification, and data analysis.
Read the full article: Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics //
Source: https://www.businesswire.com/news/home/20250603323690/en/Bruker-Announces-Acquisition-of-biocrates-a-Leader-in-Mass-Spectrometry-based-Quantitative-Metabolomics